HUP0000812A2 - Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére - Google Patents
Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezeléséreInfo
- Publication number
- HUP0000812A2 HUP0000812A2 HU0000812A HUP0000812A HUP0000812A2 HU P0000812 A2 HUP0000812 A2 HU P0000812A2 HU 0000812 A HU0000812 A HU 0000812A HU P0000812 A HUP0000812 A HU P0000812A HU P0000812 A2 HUP0000812 A2 HU P0000812A2
- Authority
- HU
- Hungary
- Prior art keywords
- peptide fragments
- multiple sclerosis
- pharmaceutical compositions
- basic protein
- myelin basic
- Prior art date
Links
- 102000007079 Peptide Fragments Human genes 0.000 title abstract 3
- 108010033276 Peptide Fragments Proteins 0.000 title abstract 3
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 title 1
- 102000047918 Myelin Basic Human genes 0.000 title 1
- 101710107068 Myelin basic protein Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000007792 addition Methods 0.000 abstract 3
- 230000037430 deletion Effects 0.000 abstract 3
- 238000012217 deletion Methods 0.000 abstract 3
- 238000006467 substitution reaction Methods 0.000 abstract 3
- 102000006386 Myelin Proteins Human genes 0.000 abstract 2
- 108010083674 Myelin Proteins Proteins 0.000 abstract 2
- 210000005012 myelin Anatomy 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Abstract
A találmány tárgya myelin bázikűs fehérje peptidfragmentűmai és azőkszűbsztitúciós, deléciós vagy addíciós származékai, feltéve, hőgy ezenszűbsztitúciók, deléciók vagy addíciók őlyan peptidet eredményeznek,amely a myelin bázikűs fehérje elleni antitesteket közömbösíti vagytermelésüket mődűlálja. A találmány őltalmi körébe tartőznak a fentipeptideket hatóanyagként tartalmazó gyógyszerkészítmények is. Atalálmány szerinti peptidfragmentűmők és azők szűbsztitúciós, deléciósvagy addíciós származékai sclerősis műltiplex kezelésére használhatók. ŕ
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2201841A CA2201841C (en) | 1997-04-04 | 1997-04-04 | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| PCT/CA1998/000290 WO1998045327A1 (en) | 1997-04-04 | 1998-04-03 | Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0000812A2 true HUP0000812A2 (hu) | 2000-09-28 |
| HUP0000812A3 HUP0000812A3 (en) | 2000-10-30 |
| HU226768B1 HU226768B1 (en) | 2009-09-28 |
Family
ID=4160340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000812A HU226768B1 (en) | 1997-04-04 | 1998-04-03 | Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP1394178B1 (hu) |
| JP (1) | JP4173557B2 (hu) |
| AT (2) | ATE400582T1 (hu) |
| AU (1) | AU751303B2 (hu) |
| CA (2) | CA2494338C (hu) |
| CY (2) | CY1107445T1 (hu) |
| CZ (1) | CZ299535B6 (hu) |
| DE (2) | DE69839694D1 (hu) |
| DK (2) | DK1394178T3 (hu) |
| ES (2) | ES2307317T3 (hu) |
| HK (1) | HK1063805A1 (hu) |
| HU (1) | HU226768B1 (hu) |
| NO (1) | NO325018B1 (hu) |
| NZ (1) | NZ338091A (hu) |
| PL (1) | PL191965B1 (hu) |
| PT (2) | PT1394178E (hu) |
| RO (1) | RO119303B1 (hu) |
| RU (1) | RU2198893C2 (hu) |
| SK (1) | SK285815B6 (hu) |
| UA (1) | UA60331C2 (hu) |
| WO (1) | WO1998045327A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1541105A (zh) | 2001-06-11 | 2004-10-27 | 转新疗法公司 | 用维生素b12和干扰素联合治疗病毒性、增殖性和炎性疾病的方法 |
| CN101353094B (zh) * | 2008-09-22 | 2011-04-13 | 刘年路 | 密闭瓶状软塑料袋及其应用 |
| KR20120103591A (ko) | 2009-10-12 | 2012-09-19 | 라이프바이오 라보라토리즈 엘엘씨 | 다발성 경화증 치료용 조성물 |
| RU2646817C1 (ru) * | 2016-12-27 | 2018-03-07 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Пептид из состава тяжелой цепи иммуноглобулина человека, пригодный для лечения рассеянного склероза |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817629A (en) * | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| CA2053799C (en) * | 1991-10-22 | 2002-03-12 | Kenneth G. Warren | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| ES2172044T3 (es) * | 1992-04-09 | 2002-09-16 | Autoimmune Inc | Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina. |
| US5824315A (en) * | 1993-10-25 | 1998-10-20 | Anergen, Inc. | Binding affinity of antigenic peptides for MHC molecules |
| HUT77047A (hu) * | 1994-10-25 | 1998-03-02 | Immulogic Pharmaceutical Corporation | Szklerózis multiplex kezelésére szolgáló készítmények és kezelések |
| US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
-
1997
- 1997-04-04 CA CA002494338A patent/CA2494338C/en not_active Expired - Fee Related
- 1997-04-04 CA CA2201841A patent/CA2201841C/en not_active Expired - Fee Related
-
1998
- 1998-03-04 UA UA99116049A patent/UA60331C2/uk unknown
- 1998-04-03 DK DK03022727T patent/DK1394178T3/da active
- 1998-04-03 RO RO99-01064A patent/RO119303B1/ro unknown
- 1998-04-03 PL PL336085A patent/PL191965B1/pl not_active IP Right Cessation
- 1998-04-03 ES ES98914725T patent/ES2307317T3/es not_active Expired - Lifetime
- 1998-04-03 AT AT98914725T patent/ATE400582T1/de not_active IP Right Cessation
- 1998-04-03 EP EP03022727A patent/EP1394178B1/en not_active Expired - Lifetime
- 1998-04-03 RU RU99122954/04A patent/RU2198893C2/ru not_active IP Right Cessation
- 1998-04-03 WO PCT/CA1998/000290 patent/WO1998045327A1/en active IP Right Grant
- 1998-04-03 SK SK1329-99A patent/SK285815B6/sk not_active IP Right Cessation
- 1998-04-03 CZ CZ0346499A patent/CZ299535B6/cs not_active IP Right Cessation
- 1998-04-03 NZ NZ338091A patent/NZ338091A/en unknown
- 1998-04-03 AT AT03022727T patent/ATE386941T1/de not_active IP Right Cessation
- 1998-04-03 DE DE69839694T patent/DE69839694D1/de not_active Expired - Lifetime
- 1998-04-03 DE DE69839163T patent/DE69839163T2/de not_active Expired - Lifetime
- 1998-04-03 PT PT03022727T patent/PT1394178E/pt unknown
- 1998-04-03 ES ES03022727T patent/ES2299657T3/es not_active Expired - Lifetime
- 1998-04-03 EP EP98914725A patent/EP0970121B1/en not_active Expired - Lifetime
- 1998-04-03 AU AU69130/98A patent/AU751303B2/en not_active Ceased
- 1998-04-03 JP JP54217098A patent/JP4173557B2/ja not_active Expired - Fee Related
- 1998-04-03 DK DK98914725T patent/DK0970121T3/da active
- 1998-04-03 HU HU0000812A patent/HU226768B1/hu not_active IP Right Cessation
- 1998-04-03 PT PT98914725T patent/PT970121E/pt unknown
-
1999
- 1999-10-01 NO NO19994806A patent/NO325018B1/no not_active IP Right Cessation
-
2004
- 2004-09-01 HK HK04106565A patent/HK1063805A1/xx not_active IP Right Cessation
-
2008
- 2008-04-24 CY CY20081100462T patent/CY1107445T1/el unknown
- 2008-08-05 CY CY20081100818T patent/CY1108239T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY106315A (en) | Pharmaceutical agents | |
| MXPA02011303A (es) | Nueva composicion farmaceutica. | |
| HUP0000589A2 (hu) | Vizes peptid készítmények | |
| HUP9903906A2 (hu) | Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál | |
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| DE69715888D1 (de) | Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel | |
| HUP0001293A1 (hu) | Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására | |
| HUP0102521A2 (hu) | Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer | |
| HUP9701059A2 (hu) | Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására | |
| HUP9801240A2 (en) | Oral compositions | |
| NO972451L (no) | Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav | |
| IE841734L (en) | Modified protease inhibitors | |
| HUP0301349A2 (hu) | IL-11-tartalmú készítmények | |
| IL91276A0 (en) | Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases | |
| HUP9700826A1 (hu) | Peptikus fekély elleni gyógyászati készítmények | |
| FI972308A0 (fi) | 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi | |
| HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
| DE69033970D1 (de) | Huperzin a analoge verbindungen | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
| NO972449L (no) | Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav | |
| NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| HUP0000812A2 (hu) | Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére | |
| SE8402199D0 (sv) | Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |